Ono Pharmaceutical (OPHLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 634,846 | 539,829 | 615,781 | 1,306,460 | 986,471 |
| Marketable Securities | 289,009 | 103,383 | 193,428 | 164,097 | 199,852 |
| Receivables | 706,873 | 686,565 | 731,862 | 654,062 | 553,953 |
| Inventories | 302,735 | 295,389 | 295,189 | 226,194 | 207,430 |
| Other current assets | 138,579 | 126,387 | 139,817 | 69,121 | 48,479 |
| TOTAL | $2,072,042 | $1,751,553 | $1,976,077 | $2,419,934 | $1,996,185 |
| Non-Current Assets | |||||
| PPE Net | 1,054,578 | 979,830 | 889,822 | 746,952 | 715,121 |
| Investments And Advances | 2,111,142 | 2,369,349 | 2,222,682 | 1,817,177 | 1,697,602 |
| Intangibles | 611,211 | 567,531 | 525,611 | 403,900 | 342,181 |
| Other Non-Current Assets | 346,730 | 227,250 | 133,220 | 125,081 | 74,355 |
| TOTAL | $4,123,661 | $4,143,960 | $3,771,335 | $3,093,110 | $2,829,259 |
| Total Assets | $6,195,685 | $5,895,504 | $5,747,411 | $5,513,043 | $4,825,445 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,915 | 3,694 | 3,778 | 2,930 |
| Accounts payable and accrued liabilities | 316,839 | 331,497 | 320,894 | 275,936 | 279,021 |
| Other current liabilities | 316,075 | 269,118 | 238,869 | 239,539 | 125,270 |
| TOTAL | $840,227 | $748,350 | $645,930 | $740,477 | $466,019 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 15,885 | 3,015 | 4,841 | 4,602 |
| Other Non-Current Liabilities | 118,220 | 55,908 | 91,411 | 77,239 | 92,744 |
| TOTAL | $129,656 | $82,530 | $105,079 | $92,112 | $107,148 |
| Total Liabilities | $969,882 | $830,889 | $751,008 | $832,587 | $573,166 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 514,122 | 530,019 | N/A |
| Common Shares | 159,694 | 156,222 | 163,757 | 154,985 | 154,985 |
| Retained earnings | 4,826,366 | 4,491,792 | 4,339,480 | 4,394,976 | 4,044,489 |
| Other shareholders' equity | 493,236 | 604,792 | 691,142 | 507,421 | 430,097 |
| TOTAL | $5,225,802 | $5,064,624 | $4,996,403 | $4,680,456 | $4,252,279 |
| Total Liabilities And Equity | $6,195,684 | $5,895,513 | $5,747,411 | $5,513,043 | $4,825,445 |